Arexvy® RSV vaccine added to National Immunisation Program

National Immunisation Program update- RSV adult vaccination

The RSV adult vaccine, Arexvy®, has been included on the National Immunisation Program (NIP) for the below two cohorts;

  1. All people from 75 years of age 
  2. Aboriginal and Torres Strait Islander people from 60 years of age
     
  • A single dose of RSV vaccine is recommended for these cohorts due to their increased risk of complications from RSV infection and hospitalisation. 
  • The increased burden of RSV disease among older adult populations is experienced at an earlier age in the Aboriginal and Torres Strait Islander population. 
  • The Arexvy RSV vaccine can be administered at any time of year and can be co-administered with other vaccines such as COVID-19, influenza, pneumococcal and zoster.
  • Adults who have previously had an RSV infection, should receive the vaccine once they have recovered.
  • The need for further doses in older people has not yet been established

Arexvy® can be ordered through the Vaccine Distribution Centre (VDC). Immunisation providers are encouraged to monitor the VDC Noticeboard and emails for further updates. 

There will be three funded RSV immunisation products available in 2026.

The RSV immunisation product alert resource has been developed to assist providers administering RSV products to ensure the correct RSV product is administered to the correct eligible cohort. This resource can be printed and used to label baskets in vaccination fridges and placed in other prominent clinical areas to reduce the risk of program errors. 

New NIP South Australian Schedules

The  National Immunisation Program-South Australia Schedule has now been updated into two separate resources:

Hard copy versions have been sent to all immunisation providers registered with VDC; additional copies can also be downloaded from the SA Health Immunisation Resources page.

 For further information of RSV immunisation programs and vaccines see:

13 May 2026